Skip to main content
MESA LABORATORIES INC /CO/ logo

MESA LABORATORIES INC /CO/ — Investor Relations & Filings

Ticker · MLAB ISIN · US59064R1095 LEI · 549300ZCG738WLX8ZW79 US Manufacturing
Open in API
Filings indexed 1,017 across all filing types
Latest filing 2016-07-28 Earnings Release
Country US United States of America
Listing US MLAB

About MESA LABORATORIES INC /CO/

https://mesalabs.com

Mesa Laboratories, Inc. designs, manufactures, and markets quality control products and services for regulated industries. The company specializes in life sciences tools and critical quality control solutions, including analytical instruments and related consumables. Its products are utilized primarily in the pharmaceutical, healthcare, and medical device sectors to ensure product safety, integrity, and performance. Mesa Laboratories focuses on applying technical expertise and technological innovation to help customers monitor and maintain high standards, supporting compliance with various regulatory requirements and international standards for quality management, testing, and calibration.

Recent filings

Filing Released Lang Actions
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions "ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION" and that a press release with quarterly results for the three months ended June 30, 2016, is furnished as an exhibit. The document itself is short (2669 characters) and primarily serves to announce the earnings release via the attached press release. According to the rules, if a document is short and announces a report or press release, it should be classified as an Earnings Release (ER) if it contains key highlights of quarterly financial results. Since this 8-K includes a press release about quarterly results, it fits the Earnings Release category rather than a full Interim Report or Regulatory Filing. Therefore, the appropriate classification is ER with high confidence.
2016-07-28 English
FORM 8-K
M&A Activity Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text specifically mentions the acquisition of certain assets and liabilities of HANSAmed Limited by a subsidiary of Mesa Laboratories, Inc. This indicates a merger and acquisition related event. The document is not a full annual or quarterly report, nor is it a simple announcement of a report publication. It is a regulatory filing reporting a significant corporate event, specifically an acquisition. Therefore, the most appropriate classification is 'M&A Activity' (TAR). The document length is short and focused on the acquisition event, consistent with a Form 8-K reporting M&A activity.
2016-07-05 English
PRIMARY DOCUMENT
Director's Dealing
2016-06-23 English
PRIMARY DOCUMENT
Director's Dealing
2016-06-13 English
FORM 8-K
Investor Presentation Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated June 7, 2016, for Mesa Laboratories, Inc. It specifically states that it is furnishing a PowerPoint presentation used for an investor presentation on June 7, 2016. The document is relatively short (3344 characters) and primarily serves to attach and disclose the investor presentation. There is no detailed financial data or comprehensive report content within this document itself. According to the classification rules, a document that provides a presentation for investors focusing on financials, strategy, and market position is classified as an Investor Presentation (IP).
2016-06-10 English
PRIMARY DOCUMENT
Director's Dealing
2016-06-08 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.